HCC Rights Issue Launch
The Hindustan Construction Company Ltd. (HCC) is ready to issue an overall ₹1,000 crore rights issue on Friday, December 12. This fund-raising exercise enables the company to raise as much capital as possible without incurring any increment in the debt burden. The rights issue will enable HCC to issue numerous equity shares to its current shareholders at a reduced price, thus giving them room to retain or increase their share in the company.
The technique is common among firms that want to shore up their balance sheets, fund their expansion plans, or satisfy working capital needs in an efficient and effective way.
HCC Rights Issue: Key Stock & Subscription Details
| Category | Details |
|---|---|
| Stock Movement & Pricing | Since the record date (December 5), HCC shares have declined nearly 14%. Issue price is ₹12.5 per share, a 34% discount to Thursday’s closing price. |
| Issue Details | HCC’s board plans to issue 79.99 crore rights equity shares. |
| Share Allocation | Eligible shareholders will receive 277 rights equity shares for every 630 fully paid-up equity shares held as of the record date. |
| Eligibility & Record Date | Shareholders holding HCC shares in their demat account as of December 4 are eligible to participate. |
HCC Rights Issue: Renunciation Window & What It Means to You
And you, HCC shareholder, need to know where you go here, so here is the amusing part, renunciation! The on-market renunciation window closes on Wednesday, December 17, and it provides you with an opportunity to exercise your rights as is the case with regular shares. Prefer a little more privacy? You may go with the off-market line until Friday, the 19th of December. On-market renunciations allow shareholders to sell their rights to willing buyers at a price of their own choice, providing a tidy means of monetising the rights without subscribing to the issue. It is flexibility enclosed in opportunity.
HCC Rights Issue: Post-Issue Shareholding Shake-Up
And this is the ginger, when the rights issue completes, total outstanding shares of HCC will soar to 261 crore as compared to 181 crore. That represents one huge share-base growth, one that would transform the market. It remains to be seen whether you will be a subscriber, seller of rights, or even a spectator, but this rights issue is proving to be a pivotal point in the future of HCC.
(With Inputs)
Also Read: Nephrocare IPO Closes Today: GMP Signals Likely Premium Listing – Last Day…

